TABLE 3.

Progression Free survival (PFS) and Overall Survival (OS) After Treatment With PRRT

Variable	PFS			OS
	HR	95% CI	P	HR	95% CI	P
Sex, male	1.23	0.46–3.30	0.68	0.86	0.27–2.73	0.80
Pancreatic primary	0.85	0.33–2.17	0.73	1.37	0.44–4.26	0.59
Small bowel primary	1.29	0.45–3.69	0.63	0.64	0.14–2.93	0.56
WHO grade III	3.41	1.13–10.30	0.03	3.61	1.04–12.60	0.04
Age >60 years at start of PRRT	0.50	0.19–1.32	0.16	1.08	0.34–3.43	0.90
Total treatments prior to PRRT	1.24	0.62–2.47	0.60	1.19	0.52–2.74	0.68
Non-hepatic surgery	0.78	0.22–2.76	0.71	0.62	0.13–2.90	0.55
Liver directed therapy	0.45	0.16–1.28	0.13	0.50	0.13–1.89	0.31
Chemotherapy	4.76	1.64–13.77	<0.01	3.53	1.08–11.55	0.04
Hepatic tumor burden (≥25%)	2.49	0.76–8.19	0.13	1.42	0.37–5.39	0.61

Bolded values are statistically significant with a P < 0.05.